Truth in Publishing?

UPDATE 4-14-14:  A "friend" of Adams posts this expose on another fraud in supplements Adams is selling.
Can You Trust Your Supplements: http://jonbarron.org/dietary-supplements/can-you-trust-your-supplements

As it stands now, based on some recently uncovered information, the "health ranger" is now a "News Journalist".

Software creator to "editor" and also a so-called independent reviewer.

You have to be the real judge of exactly what color chameleon it is today.  Might have been different yesterday, perhaps different tomorrow.

As I've mentioned I have been copied from the inception of this wunderkind's creations.  He started lurking in 2003 and copying without attribution.  Could be flattery, maybe.  But what about his defamation, and I've never even talked with the fellow.

I've always stood on the fact that I have worked in media with many well respected companies over the years, and I follow ethical practices.

Here's one thing you might find interesting. If there was real transparency that would be better. After all, isn't it "Truth Publishing"?
Sound too good to be true? That's what I thought at first, too. But then I took the time to meet the people, research the rainforest herbs and experience their healing effects myself. Now I'm not only convinced this is the company that's going to pave the way to sustainable business practices in the coming years, I'm also convinced it represents the very best business opportunity available in the natural health industry today for anyone interested in an independent, at-home business where you control your own financial destiny. That's no casual claim, either. Keep reading to see why I've become such an outspoken advocate of the Amazon Herb Company, even while refusing to become a associate myself (due to journalism ethics, because if I got involved with the company, I could no longer offer a truly independent opinion like what you're reading here).
This person is connected with the Wyoming software company linked with Adams


DONA C COPELAND
SECRETARY
1501 STAMPEDE AVENUE, #9005
CODY,WY 82414
Date of Taking Office: 03/12/2009
Last Updated: 03/06/2014

http://www.naturalnews.com/Report_Amazon_Herb_Company_0.html
Corporation documents filed in Arizona over quite a few years show otherwise -


http://starpas.azcc.gov/scripts/cgiip.exe/WService=wsbroker1/names-detail.p?name-id=05225664&type=CORPORATION


Arizona Corporation Commission
04/11/2014State of Arizona Public Access System11:58 AM

Jump To...
Annual Reports Scanned Documents Amendments Microfilm

Corporate Inquiry
File Number:  -0522566-4
Corp. Name: CONSUMER WELLNESS CENTER
Domestic Address
6336 N. ORACLE ROAD, #326-315
TUCSON,  AZ  85704
Statutory Agent Information
Agent Name:  MICHAEL ADAMS
Agent Mailing Address:
6336 N. ORACLE ROAD,
#326-315
TUCSON,  AZ  85704
Agent Physical Address:
180 W. MAGEE ROAD
STE. 116
ORO VALLEY,  AZ  85704
Agent Status: APPOINTED 01/31/2007
Agent Last Updated: 09/16/2008
Additional Corporate Information
Corporation Type: NON-PROFITBusiness Type: EDUCATIONAL
Incorporation Date:  01/22/1990Corporate Life Period: PERPETUAL
Domicile:  ARIZONACounty: PIMA
Approval Date:  01/25/1990Original Publish Date:  06/07/1990

Officer Information

MICHAEL ADAMS
PRESIDENT
6336 N. ORACLE ROAD, #326-315
TUCSON,AZ 85704
Date of Taking Office: 12/07/2006
Last Updated: 03/06/2014

DONA C COPELAND
SECRETARY
1501 STAMPEDE AVENUE, #9005
CODY,WY 82414
Date of Taking Office: 03/12/2009
Last Updated: 03/06/2014

SHEH ADAMS
TREASURER
6336 N. ORACLE ROAD, #326-315
TUCSON,AZ 85704
Date of Taking Office: 02/27/2007
Last Updated: 03/06/2014

 

Director Information

SHEH ADAMS
DIRECTOR
6336 N. ORACLE ROAD, #326-315
TUCSON,AZ 85704
Date of Taking Office: 02/27/2007
Last Updated: 03/06/2014

MICHAEL ADAMS
DIRECTOR
6336 N. ORACLE ROAD, #326-315
TUCSON,AZ 85704
Date of Taking Office: 12/07/2006
Last Updated: 03/06/2014

Annual Reports

Next Annual Report Due: 02/22/2015
File Year File Month Date Received Reason ReturnedDate Returned Extension
20140202/18/2014
20130202/19/2013
20120202/19/2013
20110202/15/2011
20100202/01/2010
20090204/06/2009
20080205/30/2008
20070204/23/200708/22/2008
20060210/18/2006
20050206/02/2005
20040209/13/2004
20030202/24/2003
20020203/21/2002
20010205/15/2001
20000203/30/2000
19990202/23/1999
19980204/23/1998
19961001/30/1997
19951005/03/1996
19941002/17/1995REPLACEMENT CHECK04/29/199604/15/1996
19931003/15/199404/15/1995
19921002/17/1993
19911002/14/1992
19901002/14/1991
Back To Top

Look at these *** in particular 

Scanned Documents
(Click on gray button - if present - to view document - will open in a new window.)
(If gray button is not present, please check back later.)
Document NumberDescriptionDate Received
96 ANNUAL REPORT ***01/30/1997
98 ANNUAL REPORT04/23/1998
99 ANNUAL REPORT02/23/1999
00 ANNUAL REPORT03/30/2000
01 ANNUAL REPORT05/15/2001
02 ANNUAL REPORT03/21/2002
03 ANNUAL REPORT02/24/2003
04 ANNUAL REPORT09/13/2004
05 ANNUAL REPORT06/02/2005
06 ANNUAL REPORT10/18/2006
PUB OF AMENDMENT ***02/22/2007
07 ANNUAL REPORT04/23/2007
08 ANNUAL REPORT05/30/2008
CHANGE(S)09/11/2008
09 ANNUAL REPORT04/06/2009
10 ANNUAL REPORT02/01/2010
11 ANNUAL REPORT02/15/2011
12 ANNUAL REPORT02/17/2012
13 ANNUAL REPORT02/19/2013
14 ANNUAL REPORT02/18/2014
Back To Top
Amendments
Amendment Date Amendment Type Publish Date Publish Exception
01/31/2007NAME CHANGE02/22/2007     
09/18/1990AMENDMENT10/16/1990     
Back To Top
Name Changes / Mergers
Description Corporation Name Date
CHANGED FROMTERRA CHRISTA COMMUNICATIONS, INC.01/31/2007

Microfilm
Location Date Received Description
1050800902901/22/1990ARTICLES
2010005501806/07/1990PUBLICATION OF ARTICLES
1056900803509/18/1990AMENDMENT
2010506101010/16/1990PUBLICATION OF AMENDMENT
1059400203202/14/199190 ANNUAL REPORT
1066302100802/14/199291 ANNUAL REPORT
1073701203102/17/199392 ANNUAL REPORT
1083302303003/15/199493 ANNUAL REPORT
2016803003802/16/199594 EXTENSION
1092202303502/17/199594 ANNUAL REPORT
2018901200802/16/199695 EXTENSION
2019208601104/25/1996DELINQUENT NOTICE/MAIL RETURNED
1104102100605/03/199695 ANNUAL REPORT
2019800100209/04/1996AGENT APPOINTMENT/CORP ADDR CHG
1110701003201/30/199796 ANNUAL REPORT
1122101803503/20/199898 ANNUAL REPORT
3152400200802/23/199999 ANNUAL REPORT
2024703601107/02/1999CORP ADDRESS CHG
3157300026503/30/200000 ANNUAL REPORT
3161900013905/15/200101 ANNUAL REPORT
3165700021303/21/200202 ANNUAL REPORT
3170800126802/24/200303 ANNUAL REPORT
3179100102407/13/2004NOTICE OF PENDING ADMINISTRATIVE DISSOLUTION
3182600064309/13/200404 ANNUAL REPORT
3188600051806/02/200505 ANNUAL REPORT
3201100263410/18/200606 ANNUAL REPORT
1177600104001/31/2007AMENDMENT
3202900401802/22/2007PUB OF AMENDMENT
3205200196604/23/200707 ANNUAL REPORT
1180200901302/15/2008EXTENSION
3215800042805/30/200808 ANNUAL REPORT
3216200329309/11/2008CHANGE(S)


Share:

Simply 4 Alzheimer's


Make sure you are using fully natural vitamin E, no synthetics: "The hell with dl" 

Despite the occasional negative publicity surrounding vitamin E, this nutrient has proven itself time and again to be one amazing antioxidant. Case in point: Research published earlier this year in the Journal of the American Medical Association has shown that vitamin E can help slow functional decline associated with Alzheimer’s disease.1

This development is particularly significant since no cure for Alzheimer’s exists—only treatments to slow the progression of the disease. Currently, two main classes of drugs are approved for Alzheimer’s treatment: cholinesterase inhibitors (such as Aricept®, Exelon® and Razadyne®) and memantine (Namenda®).

These drugs may treat the symptoms of Alzheimer’s—like memory loss and problems with reasoning—but they also have their fair share of troublesome side effects, including nausea, vomiting, loss of appetite, increased bowel movements, headache and dizziness.

Researchers have found, however, that vitamin E may actually work better than certain conventional treatments in slowing cognitive decline.

In this randomized, double-blind, placebo-controlled study, investigators wanted to determine the effectiveness of vitamin E, mematine or a combination of the two in slowing the progression of mild to moderate Alzheimer’s disease in patients already taking a cholinesterase inhibitor like Aricept®.

Participants received 2,000 IU vitamin E (alpha tocopherol) per day, 20 mg memantine per day, a combination of the two or a placebo.

At the end of the five-year study period, the researchers analyzed data from 561 of the participants (140 taking vitamin E, 142 taking memantine, 139 using the combination treatment and 140 on placebo). They found that the group given the vitamin E had a delay in clinical progression of the disease of 19 percent per year (in other words, a delay of 6.2 months) compared to the placebo group.

In addition, those in the vitamin E group did not demand increased attention from caregivers.

More importantly, contrary to other studies that have implicated vitamin E as the cause of increased mortality—especially at higher doses2-3—this study actually concluded that vitamin E has a good safety profile, with greater death frequency in the groups that took the memantine or the vitamin E/memantine combination than the vitamin E group.

In conclusion, the researchers wrote that, among patients with mild to moderate Alzheimer’s, “2,000 IU/day of alpha tocopherol compared with placebo resulted in slower functional decline. There were no significant differences in the groups receiving memantine alone or memantine plus alpha tocopherol. These findings suggest benefit of alpha tocopherol in mild to moderate Alzheimers disease by slowing functional decline and decreasing caregiver burden.”

This isn’t the first study to praise vitamin E’s brain-protective powers. Another study showed that people with the highest plasma levels of total vitamin E, total tocopherols and total tocotrienols had a reduced risk of developing Alzheimer’s disease compared to those with the lowest levels.4
 
Specifically, people with the highest plasma total vitamin E or total tocopherols had a 45 percent decreased risk of developing the disease, and those with the highest total tocotrienols had a 54 percent reduction in risk, as compared to people with the lowest levels.

Is E an Option for You?

Only a qualified medical professional—ideally one with vast knowledge in nutritional supplementation—can determine whether or not high doses of vitamin E would be appropriate for you or your loved one with Alzheimer’s.

The recommended daily allowance for healthy adults is a meager 22.4 IU, but tolerable upper intake levels go as high as 1,500 IU.5 The JAMA study used 2,000 IU. For general brain and memory health/maintenance, 400 IU per day should suffice.

In many cases, the risks of disease progression far outweigh any potential risks of taking high doses of certain drugs or supplements—but only you and your doctor can make that determination. But, as this study shows, vitamin E offers great promise, and its potential should not be ignored.

References:
  1. Dysken MW, et al. JAMA. 2014 Jan 1;311(1):33-44.
  2. Miller ER 3rd, et al. Ann Intern Med. 2005 Jan 4;142(1):37-46.
  3. Boothby LA and Doering PL. Ann Pharmacother. 2005 Dec;39(12):2073-80.
  4. Mangialasche F, et al. J Alzheimers Dis. 2010;20(4):1029-37.
  5. Institute of Medicine. http://iom.edu/Activities/Nutrition/SummaryDRIs/~/media/Files/Activity%20Files/Nutrition/DRIs/New%20Material/4_%20UL%20Values_Vitamins%20and%20Elements.pdf.
SOURCE: Larissa Long


Selections from Natural Health News



Dec 27, 2009
Increased oxidative stress and mitochondrial dysfunction have been identified as common pathophysiological phenomena associated with neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease ...
Sep 12, 2010
Cancer, Alzheimer's · Flaraxin is effective in 90% of oncologic diseases. Alzheimer's = Flaraxin + B3 http://naturalhealthnews.blogspot.com/2009/05/alzheimers-what-you-wont-see-on-hbo.html. Posted by herbalYODA at 11:56.
Jan 10, 2009
LONDON – Anti-psychotic drugs commonly used to treat Alzheimer's disease may double a patient's chance of dying within a few years, suggests a new study that adds to concerns already known about such medications.
Jan 11, 2010
According to the report, the equivalent of fluoridated drinking water in terms of elemental fluorine levels had an impact on brain tissue similar to the pathological changes found in humans with Alzheimer's and other forms of ...


Oct 12, 2011
My experience with these reports and the studies is that there are problems from the outset; the first being the use of SYNTHETIC vitamins (in this case dl-alpha tocopherol or synthetic vitamin E). This is the first mistake.
Aug 16, 2010
I think it would be a great service to patients with pain, FMS, and neuropathy if SIM started a study to show you just how effective natural vitamin E can be to prevent and reverse neuropathy. Contact us FMI, and be sure to ...
Jan 23, 2008
Over the past several years there have been numerous reports trying to convince you that vitamin E is bad for health. One public television station even aired a program with panelist from a local Spokane WA area hospital ...
Sep 10, 2007
This is how you get confused, especially if you do to know the history of vitamin E and it's use to prevent are reverse heart disease (the medical studies on this date back to the 1940s and 50s). Natural vitamin E (listed on a ...
Share: